Background: Opioid overdose is a well-established cause of morbidity and mortality in the United States1. Naloxone is an opioid antagonist and harm-reducing treatment with a complex history of prescribing behaviors, attitudes, availability and reimbursement2. Interventions to increase appropriate co-prescription of naloxone include government mandates3 and Electronic Health Record (EHR) clinical decision support4. Our institution used [...]